THE METABOLISM OF GLYBURIDE IN SUBJECTS OF KNOWN DEBRISOQUIN PHENOTYPE

被引：18

作者：

PEART, GF ^{[1
]}

BOUTAGY, J ^{[1
]}

SHENFIELD, GM ^{[1
]}

机构：

[1] ROYAL N SHORE HOSP, DEPT CLIN PHARMACOL, ST LEONARDS, NSW 2065, AUSTRALIA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1989年 / 45卷 / 03期

关键词：

D O I：

10.1038/clpt.1989.28

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：277 / 284

页数：8

共 26 条

[1]

ASPLUND K, 1983, DIABETOLOGIA, V24, P412

[2]

AYANOGLU G, 1983, INT J CLIN PHARM TH, V21, P479

[3] BEHAVIOR OF GLIBENCLAMIDE ON REPEATED ADMINISTRATION TO DIABETIC-PATIENTS [J].

BALANT, L ;

ZAHND, GR ;

WEBER, F ;

FABRE, J .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 11 (01) :19-25

[4] COMPARISON OF PHARMACOKINETICS OF GLIPIZIDE AND GLIBENCLAMIDE IN MAN [J].

BALANT, L ;

FABRE, J ;

ZAHND, GR .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (01) :63-69

[5] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES [J].

EICHELBAUM, M ;

BERTILSSON, L ;

SAWE, J ;

ZEKORN, C .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :184-186

[6]

Evans D A, 1986, Prog Clin Biol Res, V214, P491

[7]

FELDMAN JM, 1985, PHARMACOTHERAPY, V5, P43

[8] METABOLISM AND KINETICS OF HYPOGLYCEMIC AGENT GLIPIZIDE IN MAN - COMPARISON WITH GLIBENCLAMIDE [J].

FUCCELLA, LM ;

TAMASSIA, V ;

VALZELLI, G .

JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 13 (2-3) :68-75

[9] GLIBENCLAMIDE PHARMACOKINETICS IN ACARBOSE-TREATED TYPE-2 DIABETICS [J].

GERARD, J ;

LEFEBVRE, PJ ;

LUYCKX, AS .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 27 (02) :233-236

[10] HUMAN-LIVER CYTOCHROMES-P-450 INVOLVED IN POLYMORPHISMS OF DRUG OXIDATION [J].

GUENGERICH, FP ;

DISTLERATH, LM ;

REILLY, PEB ;

WOLFF, T ;

SHIMADA, T ;

UMBENHAUER, DR ;

MARTIN, MV .

XENOBIOTICA, 1986, 16 (05) :367-378

← 1 2 3 →